Dg. Hom et al., ELEVATED EXPRESSION OF GLUTATHIONE-PEROXIDASE IN PC12 CELLS RESULTS IN PROTECTION AGAINST METHAMPHETAMINE BUT NOT MPTP TOXICITY, Molecular brain research, 46(1-2), 1997, pp. 154-160
In vivo administration of either 1-methyl-4-phenyl-1,2,3,6-tetrahydrop
yridine (MPTP) or methamphetamine (MA) produces damage to the dopamine
rgic nervous system which may be due in part to the generation of reac
tive oxygen species (ROS). The resistance of superoxide dismutase (SOD
) over-expressing transgenic mice to the effects of both MPTP and MA s
uggests the involvement of superoxide in the resulting neurotoxicity o
f both compounds. Superoxide can be converted by SOD to hydrogen perox
ide, which itself can cause cellular degeneration by reacting with fre
e iron to produce highly reactive hydroxyl radicals resulting in damag
e to proteins, nucleic acids and membrane phospholipids. Hydrogen pero
xide has also been reported to be produced via inhibition of NADH dehy
drogenase by MPP + formed during oxidation of MPTP by MAO-B and by dop
amine auto-oxidation following MA-induced dopamine release from synapt
ic vesicles within nerve terminals. To test whether hydrogen peroxide
is an important factor in the toxicity of either of these two neurotox
ins, we created clonal PC12 lines expressing elevated levels of the hy
drogen peroxide-reducing enzyme glutathione peroxidase (GSHPx). Elevat
ion of GSHPx levels in PC12 was found to diminish the rise in ROS leve
ls and lipid peroxidation resulting from MA but not MPTP treatment. El
evated levels of GSHPx also appeared to prevent decreases in transport
-mediated dopamine uptake produced via MA administration as well as to
attenuate toxin-induced cell loss as measured by either MTT reduction
or LDH release. Our data, therefore, suggest that hydrogen peroxide p
roduction likely contributes to MA toxicity in dopaminergic neurons. (
C) 1997 Elsevier Science B.V. All rights reserved.